Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
| ▸ | IAPP | P10997 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2355215 | 1.00 | PPARG (0.50) | PPARGPPARATAS1R3TAS1R1IAPP | |
| SCHEMBL17705173 | 0.92 | PPARG (0.52) | PPARGPPARATAS1R3TAS1R1TRPA1 | |
| SCHEMBL4952427 | 0.86 | PPARG (0.61) | PPARGPPARAKDM4E | |
| SCHEMBL4544178 | 0.86 | PPARG (0.47) | PPARGPPARAIAPPCES2CES1 | |
| SCHEMBL16177712 | 0.86 | PPARG (0.61) | PPARGPPARATAS1R3TAS1R1IAPP | |
| SCHEMBL27966758 | 0.86 | PPARG (0.47) | PPARGPPARATAS1R3TAS1R1TRPA1 | |
| SCHEMBL16177715 | 0.86 | PPARG (0.61) | PPARGPPARATAS1R3TAS1R1IAPP | |
| SCHEMBL4544180 | 0.86 | PPARG (0.47) | PPARGPPARAIAPPCES2CES1 | |
| SCHEMBL4422070 | 0.84 | PPARG (0.70) | PPARGPPARAKDM4E | |
| SCHEMBL4422072 | 0.84 | PPARG (0.70) | PPARGPPARAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161235-A | Preparation method of ethyl linalool | 福建瑞昕商贸有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-114933518-B | Synthesis method of ethyl heptenone and application of heteropoly acid catalyst | 山东新和成药业有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-114933518-A | Synthesis method of ethyl heptenone and application of heteropoly acid catalyst | 山东新和成药业有限公司 | 2022-08-23 | — | — | CN | claimed |
| EP-0146103-B1 | USE OF 5-METHYL-2-HEPTEN-4-ONE AS A PERFUMING OR FLAVOURING AGENT, AND PERFUMING AND/OR FLAVOURING COMPOSITIONS CONTAINING THE SAME | HAARMANN & REIMER GMBH (DE) | 1987-08-05 | — | — | EP | claimed |
| CN-119161235-A | Preparation method of ethyl linalool | 福建瑞昕商贸有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-114933518-B | Synthesis method of ethyl heptenone and application of heteropoly acid catalyst | 山东新和成药业有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114933518-B | Synthesis method of ethyl heptenone and application of heteropoly acid catalyst | 山东新和成药业有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114933518-A | Synthesis method of ethyl heptenone and application of heteropoly acid catalyst | 山东新和成药业有限公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-114933518-A | Synthesis method of ethyl heptenone and application of heteropoly acid catalyst | 山东新和成药业有限公司 | 2022-08-23 | — | — | CN | disclosed |
| US-9899606-B2 | Composition for organic electroluminescent element, organic electroluminescent element, display and lighting | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-02-20 | — | — | US | disclosed |
| US-20170335355-A1 | METHOD FOR PRODUCING OXO FATTY ACID AND RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170335355-A1 | METHOD FOR PRODUCING OXO FATTY ACID AND RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-11-23 | — | — | US | disclosed |
| WO-2007121826-A1 | TRANSPORT OF ETHYNE IN FORM OF α-ALKYNOLS AS ETHYNE PRECURSORS | DSM IP ASSETS B.V. (NL) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007080103-A2 | PROCESS FOR THE PREPARATION OF ALKYNEDIOLS | DSM IP ASSETS B.V. (NL) | 2007-07-19 | — | — | WO | disclosed |
| EP-1808426-A1 | Process for the preparation of alkynediols | DSMIP Assets B.V. (NL) | 2007-07-18 | — | — | EP | disclosed |
| WO-2007039245-A1 | CLEAVAGE OF ALKYNEDIOLS | DSM IP ASSETS B.V. (NL) | 2007-04-12 | — | — | WO | disclosed |
| EP-1638913-A1 | PROCESSES FOR PREPARING BETA-HYDROXY-KETONES AND ALPHA, BETA-UNSATURATED KETONES | EASTMAN CHEMICAL COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| US-6960694-B2 | Processes for preparing β-hydroxy-ketones and α,β-unsaturated ketones | EASTMAN CHEMICAL COMPANY (US) | 2005-11-01 | — | — | US | disclosed |
| WO-2005005361-A1 | PROCESSES FOR PREPARING BETA-HYDROXY-KETONES AND ALPHA, BETA-UNSATURATED KETONES | EASTMAN CHEMICAL COMPANY (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20050004401-A1 | Processes for preparing beta-hydroxy-ketones and alpha,beta-unsaturated ketones | EASTMAN CHEMICAL COMPANY | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004401-A1 | Processes for preparing beta-hydroxy-ketones and alpha,beta-unsaturated ketones | EBP, CYP8B1, BCKDK | PPARG 776/4885PPARA 341/4885TAS1R3 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.